← Back
Data updated: Mar 10, 2026
INDOCO
Neurology
INDOCO is a generic drug manufacturer focused on Neurology.
2020
Since
2
Drugs
-
Trials
58
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2020-07-31
- Latest
- 2026-02-23
- Applications
- 2